Literature DB >> 2559664

Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements.

M J Franssen1, A M Boerbooms, R P Karthaus, W C Buijs, L B van de Putte.   

Abstract

The diffuse form of pigmented villonodular synovitis of eight knee joints of eight patients was treated by intra-articular injection of 185 MBq yttrium-90 silicate (90Y). Six patients had a recurrence of disease after one or two surgical synovectomies. After treatment with 90Y once or twice four knees showed clinical improvement with an accompanying decrease of the inflammatory activity as measured by the technetium-99m pertechnetate (99mTcO4-) uptake ratio and the severity of the diseased synovial tissue. Arthroscopy was performed before and six months after each 90Y treatment. The ratio of 99mTcO4- uptake in the inflamed compared with the normal knee joint correlated well with the macroscopical grading of pigmented villonodular synovitis. In all cases areas of persistent synovitis were found after the 90Y injection and this was confirmed both by histological examination and 99mTcO4- uptake measurements. Biopsy specimens taken from the diseased synovial areas showed histologically mostly less prominent and less numerous villi. The cartilage damage was slightly increased in only two cases. No radiological deterioration was found during follow up (mean 24 months, range 12-41). No complications of the radiosynoviortheses were noted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559664      PMCID: PMC1003940          DOI: 10.1136/ard.48.12.1007

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Yttrium 90 synovectomy--a new treatment for pigmented villonodular synovitis.

Authors:  M M O'Sullivan; D B Yates; M H Pritchard
Journal:  Br J Rheumatol       Date:  1987-02

2.  The diagnosis and treatment of pigmented villonodular synovitis.

Authors:  P D Byers; R E Cotton; O W Deacon; M Lowy; P H Newman; H A Sissons; A D Thomson
Journal:  J Bone Joint Surg Br       Date:  1968-05

3.  [Results of intraarticular treatment with 90yttrium of persistent knee effusions (author's transl)].

Authors:  R Züllig; D Gross; T Frank; A Rüttimann
Journal:  Schweiz Rundsch Med Prax       Date:  1979-09-04

4.  Pigmented villonodular synovitis: light and electron microscopic studies.

Authors:  H R Schumacher; P Lotke; B Athreya; S Rothfuss
Journal:  Semin Arthritis Rheum       Date:  1982-08       Impact factor: 5.532

5.  Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritis.

Authors:  V Kyle; B L Hazleman; E P Wraight
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

6.  Organ doses in diagnostic X-ray procedures.

Authors:  J Jankowski
Journal:  Health Phys       Date:  1984-01       Impact factor: 1.316

7.  Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review.

Authors:  B W Myers; A T Masi
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

8.  Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores.

Authors:  J W Lens; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1984-06

9.  Synovectomy of the knee with 90Y.

Authors:  P F Spooren; J J Rasker; R P Arens
Journal:  Eur J Nucl Med       Date:  1985

10.  Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90.

Authors:  D A Wiss
Journal:  Clin Orthop Relat Res       Date:  1982-09       Impact factor: 4.176

View more
  11 in total

1.  [Pigmented villonodular synovitis of the knee joint].

Authors:  P Jungbluth; K F Hopf; M Wick; H Homann; T Kagel; C Kuhnen; G Muhr; T Kälicke
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

2.  Diffuse pigmented villonodular synovitis: non-surgical management.

Authors:  J M Gumpel; D J Shawe
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

3.  Pigmented villonodular synovitis responsive to imatinib therapy.

Authors:  Wynne M Snoots; David Watkins; Dee Dockery; Robert Mennel; Brennen Scott Cheek
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

4.  Effectiveness of radiation synovectomy with Yttrium-90 and Samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, randomized, double-blinded trial.

Authors:  Marla Francisca Dos Santos; Rita Nely Vilar Furtado; Monique Sayuri Konai; Mario Luiz Vieira Castiglioni; Renata Rosa Marchetti; Constancia Pagano Gonçalves Silva; Jamil Natour
Journal:  Clin Rheumatol       Date:  2010-12-01       Impact factor: 2.980

5.  Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodular synovitis.

Authors:  Wei-Ming Chen; Po-Kuei Wu; Chien-Lin Liu
Journal:  Clin Orthop Relat Res       Date:  2012-02-23       Impact factor: 4.176

6.  Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy.

Authors:  Wael A M Nassar; Ayman Abdelaziz Bassiony; Hesham A Elghazaly
Journal:  HSS J       Date:  2008-12-19

7.  Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: clinical series and outcome.

Authors:  Jitesh K Jain; J V S Vidyasagar; Radha Sagar; Hiren Patel; Matad Lokeshwaraiah Chetan; Ashish Bajaj
Journal:  Int Orthop       Date:  2013-07-17       Impact factor: 3.075

8.  Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis.

Authors:  M E van Kasteren; I R Nováková; A M Boerbooms; J A Lemmens
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

Review 9.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991

10.  Treatment of pigmented villonodular synovitis with yttrium-90: changes in immunologic features, Tc-99m uptake measurements, and MR imaging of one case.

Authors:  D Y Chen; J L Lan; S J Chou
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.